Related Experiment Video
Updated: Jan 22, 2026

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
Published on: December 14, 2014
Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study
Anne P Starling1, John L Adgate2, Richard F Hamman1
1Department of Epidemiology, Colorado School of Public Health, Aurora, CO, USA; Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Insights
Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) is linked to infant growth differences. Maternal PFAS concentrations were associated with infant adiposity in males and weight changes in females, indicating sex-specific effects on early development.
Area of Science:
- Environmental Health
- Pediatric Endocrinology
- Toxicology
Background:
- Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) is associated with altered birth weight and childhood adiposity.
- A hypothesis suggests faster infant growth may correlate with maternal PFAS levels.
Purpose of the Study:
- To investigate the association between maternal serum PFAS concentrations during pregnancy and offspring weight and adiposity at approximately 5 months of age.
- To examine the relationship between maternal PFAS levels and infant growth trajectories in early life.
Main Methods:
- A longitudinal cohort study of 415 mother-infant pairs was conducted.
- Associations were estimated using linear and logistic regression, adjusting for confounders like maternal BMI.
- Multipollutant regression models were used to evaluate confounding by correlated exposures and effect modification by infant sex.
Main Results:
- Sex-specific associations were observed: maternal perfluorooctanoate and perfluorononanoate linked to higher adiposity in male infants.
- Maternal perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) associated with lower weight-for-age z-scores in female infants.
- One PFAS, 2-(N-methyl-perfluorooctane sulfonamido) acetate, was associated with increased odds of rapid infant growth in weight-for-age and weight-for-length.
Conclusions:
- Maternal PFAS concentrations show sex- and chemical-specific associations with infant weight and adiposity.
- Multipollutant models indicated potential confounding from correlated PFAS with opposing effects.
- While prenatal PFAS exposure may be linked to lower birth weight, rapid infant weight and fat mass gain can occur postnatally.
Background:
Prenatal exposures to certain per- and polyfluoroalkyl substances (PFAS) have been linked to lower weight and adiposity at birth but greater weight and adiposity in childhood. We hypothesized that faster growth in early infancy may be associated with maternal PFAS concentrations.
Methods:
Among 415 mother-infant pairs in a longitudinal cohort study, we estimated associations between maternal pregnancy serum concentrations of six PFAS and offspring weight and adiposity at ~5 months of age, and growth in early infancy. Linear and logistic regression models were adjusted for potential confounders including maternal pre-pregnancy body mass index. Effect modification by infant sex was evaluated. We evaluated potential confounding by correlated exposures via multipollutant linear regression and elastic net penalized regression.
Results:
Associations between maternal PFAS concentrations and infant weight and adiposity differed by offspring sex. In male infants, maternal perfluorooctanoate and perfluorononanoate were positively associated with adiposity, with percent fat mass increases of 1.5-1.7% per ln-ng/mL increase in PFAS (median adiposity at ~5 months: 24.6%). Maternal perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) were associated with lower weight-for-age z-score among female infants only (-0.26 SD per ln-ng/mL PFOS, 95% CI -0.43, -0.10; -0.17 SD per ln-ng/mL PFHxS, 95% CI -0.33, -0.01). In analyses pooled by sex, 2-(N-methyl-perfluorooctane sulfonamido) acetate above vs. below the limit of detection was associated with greater odds of rapid growth in weight-for-age (odds ratio [OR] 2.2, 95% CI 1.1, 4.3) and weight-for-length (OR 3.3, 95% CI 1.8, 6.2). Multipollutant models generally confirmed the results and strengthened some associations.
Discussion:
We observed sex- and chemical-specific associations between maternal serum PFAS concentrations and infant weight and adiposity. Multipollutant models suggested confounding by correlated PFAS with opposing effects. Although maternal PFAS concentrations are inversely associated with infant weight and adiposity at birth, rapid gain may occur in infancy, particularly in fat mass.
More Related Videos
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
Related Concept Videos
Bioavailability Study Design: Healthy Subjects Versus Patients
Deleterious Substances in Aggregate
Another type of impurity is clay and fine material that...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Connective Tissue Fibers and Ground Substance
Drug Dosing: Infants and Children
Population Growth